6-sulfatoxymelatonin has been researched along with Adenocarcinoma, Basal Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso-González, C; Cos, S; González, A; Martínez-Campa, C; Mediavilla, D; Sánchez-Barceló, EJ | 1 |
| Bartsch, C; Bartsch, H; Franz, H; Kvetnaia, T; Kvetnoy, I; Mecke, D; Molotkov, A; Raikhlin, N | 1 |
2 other study(ies) available for 6-sulfatoxymelatonin and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Body Weight; Circadian Rhythm; Darkness; Estradiol; Estrus; Female; Light; Mammary Neoplasms, Experimental; Melatonin; Rats; Rats, Sprague-Dawley; Survival Rate | 2006 |
Nocturnal urinary 6-sulfatoxymelatonin and proliferating cell nuclear antigen-immunopositive tumor cells show strong positive correlations in patients with gastrointestinal and lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Gastrointestinal Neoplasms; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Melatonin; Middle Aged; Pineal Gland; Proliferating Cell Nuclear Antigen; Radioimmunoassay | 1997 |